Scott Gottlieb
The FDA announced its draft guidance to employ a new, risk-based enforcement approach to address the public health issue of homeopathic treatments being marketed for serious diseases and/or conditions without proven clinical benefits while possibly containing harmful ingredients and being manufactured under poor practices.
“In recent years, we’ve seen a large uptick in products labeled as homeopathic that are being marketed for a wide array of diseases and conditions, from the common cold to cancer,” Scott Gottlieb, MD, commissioner of the FDA, said in a press
Uncategorized